
America’s Scientific Research: A New Opportunity for Growth After Two Years of Uncertainty
November 5, 2026/by Ayal Ronen
FreeMind Group merges Argentum life science practice creating the first global non-dilutive funding leader
October 22, 2026/by Ayal Ronen
Sachs Associates BEF, Basel, Switzerland, October 7-8, 2026
September 27, 2026/by Ayal Ronen
Sachs Associates EHIS, Basel, October 6, 2026
September 27, 2026/by Ayal Ronen
BioFuture, October 27-28, 2026, NYC
August 2, 2026/by Ayal Ronen
RESI Boston, September 22-23, 2026, Boston, USA
July 30, 2026/by Ayal Ronen
LSX USA Congress, September 23-24, 2026, Boston, USA
July 30, 2026/by Ayal Ronen
The 2026 Mid-Year Non-Dilutive Funding Landscape Report
July 20, 2026/by Ayal Ronen
SBIR Is Back — Here’s What Changed and What You Need to Do Now
June 16, 2026/by Ayal Ronen
BIO-Europe, November 9-11, 2026, Cologne, Germany
June 14, 2026/by Ayal Ronen
SBIR/STTR Program Updates: What Life Science Companies Need to Know in 2026
June 2, 2026/by Ayal Ronen
RESI San Diego, June 22, 2026 in San Diego
May 26, 2026/by Ayal RonenSearch
Recent Posts
America’s Scientific Research: A New Opportunity for Growth After Two Years of UncertaintyNovember 5, 2026 - 8:47 pm
Sachs Associates BEF, Basel, Switzerland, October 7-8, 2026September 27, 2026 - 6:51 am
Sachs Associates EHIS, Basel, October 6, 2026September 27, 2026 - 6:48 am
BioFuture, October 27-28, 2026, NYCAugust 2, 2026 - 6:59 am
RESI Boston, September 22-23, 2026, Boston, USAJuly 30, 2026 - 8:42 am
